West Pharmaceutical Services, Inc. (NYSE: WST) has provided its latest financial results for the second quarter of 2025, showing significant developments in both operational performance and financial metrics.
Positive Aspects:
Net Sales Growth: Net sales for Q2 2025 increased to $766.5 million f...